{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:58:35Z","timestamp":1771167515750,"version":"3.50.1"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.soc.2020.06.010","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T08:46:25Z","timestamp":1597135585000},"page":"581-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Thymic Malignancy\u2014Updates in Staging and Management"],"prefix":"10.1016","volume":"29","author":[{"given":"Jesse M.P.","family":"Rappaport","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: A population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jtcvs.2014.09.124","article-title":"Thymic carcinoma outcomes and prognosis: Results of an international analysis","volume":"149","author":"Ahmad","year":"2015","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jtho.2017.11.118","article-title":"Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database","volume":"13","author":"Padda","year":"2018","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.010_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.21037\/med.2019.01.03","article-title":"Case presentation and recommendations from the April 2018 ITMIG tumor board: an international multidisciplinary team","volume":"3","author":"Sigurdson","year":"2019","journal-title":"Mediastinum"},{"key":"10.1016\/j.soc.2020.06.010_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.21037\/med.2019.11.01","article-title":"Case presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team","volume":"3","author":"Sigurdson","year":"2019","journal-title":"Mediastinum"},{"key":"10.1016\/j.soc.2020.06.010_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2019.11.013","article-title":"The International Association for the Study of Lung Cancer Thymic Tumors Staging Project: The Impact of the Eighth Edition of the Union for International Cancer Control and American Joint Committee on Cancer TNM Stage Classification of Thymic Tumors","author":"Ruffini","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"issue":"7 SUPPL. 3","key":"10.1016\/j.soc.2020.06.010_bib7","article-title":"Standard report terms for chest computed tomography reports of anterior mediastinal masses suspicious for thymoma","volume":"6","author":"Marom","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"issue":"9","key":"10.1016\/j.soc.2020.06.010_bib8","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG thymic epithelial tumors staging project: Proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"11","key":"10.1016\/j.soc.2020.06.010_bib9","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.soc.2020.06.010_bib10","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A\u00a0review of 79 thymomas: Modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.soc.2020.06.010_bib11","series-title":"TNM classification of malignant tumours. 8","author":"Brierley","year":"2016"},{"issue":"5","key":"10.1016\/j.soc.2020.06.010_bib12","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/j.athoracsur.2003.10.001","article-title":"Thymic tumors","volume":"77","author":"Detterbeck","year":"2004","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.thorsurg.2010.08.001","article-title":"Management of Stage I and II Thymoma","volume":"21","author":"Detterbeck","year":"2011","journal-title":"Thorac Surg Clin"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib14","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jtho.2015.09.001","article-title":"Lymph node dissection in thymic malignancies: Implication of the itmig lymph node map, TNM stage classification, and recommendations","volume":"11","author":"Hwang","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib15","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ejcts\/ezv389","volume":"49","author":"Fukui","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12957-017-1283-4","article-title":"Evaluation of the new TNM-staging system for thymic malignancies: Impact on indication and survival","volume":"15","author":"Ried","year":"2017","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/j.soc.2020.06.010_bib17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jtho.2017.06.072","article-title":"Assessment of the ITMIG Statement on the WHO Histological Classification and of the Eighth TNM Staging of Thymic Epithelial Tumors of a Series of 188 Thymic Epithelial Tumors","volume":"12","author":"Meurgey","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.soc.2020.06.010_bib18","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib19","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: Final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","article-title":"A\u00a0phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: Report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh","year":"2010","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.soc.2020.06.010_bib22","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1556-0864(15)31586-0","article-title":"Neoadjuvant chemotherapy for stage III and IVA thymomas: a single-institution experience with a long follow-up","volume":"1","author":"Lucchi","year":"2006","journal-title":"J\u00a0Thorac Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib23","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.athoracsur.2015.04.059","article-title":"Surgical outcomes of patients with stage III thymoma in the Japanese nationwide database","volume":"100","author":"Yamada","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.athoracsur.2018.08.055","article-title":"Comparison of Neoadjuvant Chemotherapy Followed by Surgery to Upfront Surgery for Thymic Malignancy","volume":"107","author":"Park","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.soc.2020.06.010_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jtcvs.2015.08.034","article-title":"Multimodality therapy for locally advanced thymomas: A propensity score-matched cohort study from the European Society of Thoracic Surgeons Database","volume":"151","author":"Leuzzi","year":"2016","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"11","key":"10.1016\/j.soc.2020.06.010_bib26","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.jtho.2018.08.005","article-title":"Systemic Therapy in Advanced Thymic Epithelial Tumors: Insights from the RYTHMIC Prospective Cohort","volume":"13","author":"Merveilleux du Vignaux","year":"2018","journal-title":"J Thorac Oncol"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1200\/JCO.2006.08.2826","article-title":"Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: Long-term results of Southwest Oncology Group trial 9416 (Intergroup trial 0160)","volume":"25","author":"Rusch","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"22","key":"10.1016\/j.soc.2020.06.010_bib28","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1056\/NEJMoa1112088","article-title":"Preoperative chemoradiotherapy for esophageal or junctional cancer","volume":"366","author":"Van Hagen","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.soc.2020.06.010_bib29","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.athoracsur.2007.08.051","article-title":"Induction Chemoradiotherapy Followed by Resection for Locally Advanced Masaoka Stage III and IVA Thymic Tumors","volume":"85","author":"Wright","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2013.08.061","article-title":"Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: A phase II, multi-institutional clinical trial","volume":"147","author":"Korst","year":"2014","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.athoracsur.2007.10.098","article-title":"Multimodality Therapy for Locally Advanced Thymomas: State of the Art or Investigational Therapy?","volume":"85","author":"Huang","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/ejcts\/ezt649","article-title":"Tumours of the thymus: A cohort study of prognostic factors from the European Society of Thoracic Surgeons database","volume":"46","author":"Ruffini","year":"2014","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0003-4975(95)00983-3","article-title":"Surgical treatment for invasive thymoma, especially when the superior vena cava is invaded","volume":"61","author":"Yagi","year":"1996","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib35","first-page":"53","article-title":"Lympho-epithelial thymoma. Anatomo-clinical and therapeutic study of 113 cases","volume":"5","author":"Ribet","year":"1988","journal-title":"Rev Mal Respir"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib36","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1096-9098(199609)63:1<17::AID-JSO4>3.0.CO;2-T","article-title":"Preoperative radiotherapy and surgery for advanced thymoma with invasion to the great vessels","volume":"63","author":"Akaogi","year":"1996","journal-title":"J\u00a0Surg Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.athoracsur.2019.03.010","article-title":"Utilization of Minimally Invasive Thymectomy and Margin-Negative Resection for Early-Stage Thymoma","volume":"108","author":"Burt","year":"2019","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jtho.2016.08.131","article-title":"Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry","volume":"12","author":"Burt","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jtho.2015.08.004","article-title":"Minimally invasive versus open thymectomy for thymic malignancies: Systematic review and meta-analysis","volume":"11","author":"Friedant","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.21037\/acs.2019.02.04","article-title":"A\u00a0systematic review of robotic versus open and video assisted thoracoscopic surgery (VATS) approaches for thymectomy","volume":"8","author":"O\u2019Sullivan","year":"2019","journal-title":"Ann Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib41","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jtcvs.2018.04.049","article-title":"Lymph node metastasis in thymic malignancies: A Chinese multicenter prospective observational study","volume":"156","author":"Fang","year":"2018","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.010_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jtcvs.2019.08.037","article-title":"Long-term, disease-specific outcomes of thymic malignancies presenting with de novo pleural metastasis","volume":"159","author":"Choe","year":"2020","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"4","key":"10.1016\/j.soc.2020.06.010_bib43","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jtho.2017.01.002","article-title":"The Impact of Postoperative Radiotherapy for Thymoma and Thymic Carcinoma","volume":"12","author":"Jackson","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.athoracsur.2015.06.034","article-title":"The effectiveness of postoperative radiotherapy in patients with completely resected thymoma: A meta-analysis","volume":"101","author":"Zhou","year":"2016","journal-title":"Ann Thorac Surg"},{"issue":"10","key":"10.1016\/j.soc.2020.06.010_bib45","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.jtho.2016.06.011","article-title":"Postoperative radiation therapy is associated with longer overall survival in completely resected stage II and III thymoma-an analysis of the international thymic malignancies interest group retrospective database","volume":"11","author":"Rimner","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"7","key":"10.1016\/j.soc.2020.06.010_bib46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/cncr.29166","article-title":"Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: The Japanese Association for Research on the Thymus Database Study","volume":"121","author":"Omasa","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2020.06.010_bib47","doi-asserted-by":"crossref","first-page":"S2555","DOI":"10.21037\/jtd.2018.01.154","article-title":"The expanding role of radiation therapy for thymic malignancies","volume":"10","author":"Willmann","year":"2018","journal-title":"J\u00a0Thorac Dis"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/COC.0000000000000024","article-title":"Treatment modalities and outcomes in patients with advanced invasive thymoma or thymic Carcinoma a retrospective multicenter study","volume":"39","author":"Modh","year":"2016","journal-title":"Am J Clin Oncol"},{"issue":"6","key":"10.1016\/j.soc.2020.06.010_bib49","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.athoracsur.2012.03.004","article-title":"The role of adjuvant radiation therapy for resected stage III thymoma: A population-based study","volume":"93","author":"Weksler","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.soc.2020.06.010_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtcvs.2012.10.013","article-title":"Resection and heated pleural chemoperfusion in patients with thymic epithelial malignant disease and pleural spread: A single-institution experience","volume":"145","author":"Yellin","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.soc.2020.06.010_bib51","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s11748-018-01054-7","article-title":"Multimodality therapy for thymoma patients with pleural dissemination","volume":"67","author":"Nakamura","year":"2019","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib52","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/ejcts\/ezx090","article-title":"Surgical therapy of thymic tumours with pleural involvement: an ESTS Thymic Working Group Project","volume":"52","author":"Moser","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ejcts\/ezv239","article-title":"Long-term outcome and prognostic factors of surgically treated thymic carcinoma: results of 306 cases from a Japanese Nationwide Database Study","volume":"49","author":"Hishida","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2020.06.010_bib54","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.lungcan.2017.03.020","article-title":"Improved survival with postoperative radiotherapy in thymic carcinoma: A propensity-matched analysis of Surveillance, Epidemiology, and End Results (SEER) database","volume":"108","author":"Lim","year":"2017","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.soc.2020.06.010_bib55","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.athoracsur.2016.12.042","article-title":"A\u00a0Meta-Analysis of Postoperative Radiotherapy for Thymic Carcinoma","volume":"103","author":"Hamaji","year":"2017","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtcvs.2009.03.033","article-title":"Comparison of patterns of relapse in thymic carcinoma and thymoma","volume":"138","author":"Huang","year":"2009","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.soc.2020.06.010_bib57","article-title":"Pleural recurrence of thymoma: surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy\u2020","author":"Ambrogi","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.soc.2020.06.010_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2017.02.014","article-title":"Intra-Thoracic Chemo-Hyperthermia for pleural recurrence of thymoma","volume":"108","author":"Maury","year":"2017","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00432-001-0319-9","article-title":"Epidermal growth factor receptor expression in invasive thymoma","volume":"128","author":"Henley","year":"2002","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"22","key":"10.1016\/j.soc.2020.06.010_bib60","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.soc.2020.06.010_bib61","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.jtho.2016.04.013","article-title":"PI3K as a potential therapeutic target in thymic epithelial tumors","volume":"11","author":"Alberobello","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.soc.2020.06.010_bib62","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1200\/JCO.2017.74.4078","article-title":"Phase II study of everolimus in patients with thymoma and thymic carcinoma previously treated with cisplatin-based chemotherapy","volume":"36","author":"Zucali","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"16_suppl","key":"10.1016\/j.soc.2020.06.010_bib63","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1200\/jco.2005.23.16_suppl.7068","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"15_suppl","key":"10.1016\/j.soc.2020.06.010_bib64","doi-asserted-by":"crossref","first-page":"19087","DOI":"10.1200\/jco.2008.26.15_suppl.19087","article-title":"A\u00a0phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma","volume":"26","author":"Bedano","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.soc.2020.06.010_bib65","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","article-title":"Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas","volume":"4","author":"Giaccone","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"issue":"9","key":"10.1016\/j.soc.2020.06.010_bib66","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/JTO.0b013e3181e392a8","article-title":"Insulin-like growth factor-1 receptor expression in thymic malignancies","volume":"5","author":"Girard","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1470-2045(13)70596-5","article-title":"Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: A multicentre, open-label, phase 2 trial","volume":"15","author":"Rajan","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib68","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lungcan.2014.05.010","article-title":"Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: A tissue micro array-based multicenter study","volume":"85","author":"Lattanzio","year":"2014","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.soc.2020.06.010_bib69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1470-2045(14)71181-7","article-title":"Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: An open-label phase 2 trial","volume":"16","author":"Thomas","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2020.06.010_bib70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lungcan.2016.04.024","article-title":"Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network","volume":"97","author":"Remon","year":"2016","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.soc.2020.06.010_bib71","doi-asserted-by":"crossref","first-page":"e0182665","DOI":"10.1371\/journal.pone.0182665","article-title":"Expression of PD-L1 and other immunotherapeutic targets in thymic epithelial tumors","volume":"12","author":"Arbour","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.soc.2020.06.010_bib72","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/modpathol.2017.6","article-title":"Expression of PD-1 and PD-L1 in thymic epithelial neoplasms","volume":"30","author":"Weissferdt","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.soc.2020.06.010_bib73","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lungcan.2016.05.007","article-title":"Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: Impact on treatment efficacy and alteration in expression after chemotherapy","volume":"99","author":"Katsuya","year":"2016","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1470-2045(18)30062-7","article-title":"Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study","volume":"19","author":"Giaccone","year":"2018","journal-title":"Lancet Oncol"},{"issue":"24","key":"10.1016\/j.soc.2020.06.010_bib75","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1200\/JCO.2017.77.3184","article-title":"Pembrolizumab for patients with refractory or relapsed thymic epithelial tumor: An open-label phase II trial","volume":"37","author":"Cho","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2020.06.010_bib76","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2019.03.012","article-title":"Single-arm, multicentre, phase II trial of nivolumab for unresectable or recurrent thymic carcinoma: PRIMER study","volume":"113","author":"Katsuya","year":"2019","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib77","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s40425-019-0723-9","article-title":"Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma","volume":"7","author":"Rajan","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"4","key":"10.1016\/j.soc.2020.06.010_bib78","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/1097-0142(19910815)68:4<706::AID-CNCR2820680407>3.0.CO;2-H","article-title":"Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma","volume":"68","author":"Macchiarini","year":"1991","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib79","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0022-5223(19)34092-9","article-title":"Chemotherapy and operation for invasive thymoma","volume":"106","author":"Rea","year":"1993","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"5","key":"10.1016\/j.soc.2020.06.010_bib80","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/oxfordjournals.annonc.a058527","article-title":"Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: Results in six patients","volume":"4","author":"Berruti","year":"1993","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.soc.2020.06.010_bib81","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/S0003-4975(97)00629-2","article-title":"Multimodality treatment of thymoma: a prospective study","volume":"64","author":"Venuta","year":"1997","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/JTO.0b013e31802bafc8","article-title":"Multidisciplinary treatment for advanced invasive thymoma with cisplatin, doxorubicin, and methylprednisolone","volume":"2","author":"Yokoi","year":"2007","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.soc.2020.06.010_bib83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.lungcan.2003.09.022","article-title":"Multimodal management of stages III-IVa malignant thymoma","volume":"44","author":"Bretti","year":"2004","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.soc.2020.06.010_bib84","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/j.cllc.2019.06.011","article-title":"Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study","volume":"20","author":"Ma","year":"2019","journal-title":"Clin Lung Cancer"},{"issue":"3","key":"10.1016\/j.soc.2020.06.010_bib85","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/icvts\/ivy276","article-title":"Long-term outcomes of advanced thymoma in patients undergoing preoperative chemotherapy or chemoradiotherapy followed by surgery: A 20-year experience","volume":"28","author":"Kanzaki","year":"2019","journal-title":"Interact Cardiovasc Thorac Surg"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320720300508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:04:03Z","timestamp":1760961843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320720300508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1055320720300508"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2020.06.010","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymic Malignancy\u2014Updates in Staging and Management","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2020.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}